Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain- and...

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease often linked to mutations in the SOD1 gene.
• Existing transgenic animal models for SOD1-ALS may confound results due to protein overexpression.
• Understanding the precise mechanisms of mutant SOD1 toxicity is crucial for ALS research.

Purpose of the Study:

• To develop a Drosophila model that recapitulates ALS-like phenotypes without SOD1 overexpression.
• To investigate the role of specific SOD1 mutations in disease pathogenesis.
• To create a tool for genetic studies of SOD1-ALS.

Main Methods:

• Genetically engineered four human ALS-associated SOD1 point mutations into the endogenous Drosophila SOD1 locus using homologous recombination.
• Analyzed molecular, biochemical, and behavioral phenotypes in the resulting Drosophila models.
• Compared phenotypes with controls and SOD1 null animals.

Main Results:

• Recapitulated ALS-like phenotypes, including neurodegeneration, locomotor deficits, and shortened lifespan, without overexpression of mutant SOD1.
• Mutations rendering SOD1 enzymatically inactive (G85R, H48R, H71Y) caused significant phenotypes.
• The mutation retaining enzymatic activity (G37R) did not induce phenotypes, suggesting enzymatic activity is not the sole driver of toxicity.
• Phenotypes were largely recessive but showed a gain-of-function component in dosage studies.

Conclusions:

• The Drosophila knock-in model accurately reflects key aspects of human SOD1-based ALS.
• This model provides a valuable platform for dissecting the genetic and molecular underpinnings of SOD1-ALS.
• The findings highlight the importance of specific SOD1 mutations beyond simple overexpression in ALS pathogenesis.